Vice President of Pharmacovigilance
As vice president of pharmacovigilance, Cindy Elko-Simms, M.D., has primary responsibility for all global pharmacovigilance (PVG) services for clinical trials and marketed products and supporting functions. She ensures regulatory compliance and efficient execution of safety services, as well as appropriate hiring, performance management and training of PVG staff. She sets the strategic vision for departmental business process optimization and technology planning. She supports strategic partnership relationships at executive-level interactions and serves as the chair for the executive medical risk review committee, which is responsible for addressing escalated potential patient safety issues within PPD.